HMGB1 and myocardial infarction: Hence, in both acute and chronic MI higher levels of cardiac HMGB1 or exogenous administration of fr-HMGB1 elicits protective effects by modulating inflammation, enhancing cardiomyocytes regeneration and angiogenesis, and reducing fibrosis (Table 2).